CCL20 and breast cancer: To examine how CCL20 contributes to bone metastasis of breast cancer cells, we evaluated the effects of CCL20 treatment on the proliferation (Fig. 5a,b), migration (Fig. 5c), and invasion (Fig. 5d) of MDA-MB-231 cells.